Fig. 3From: Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinicsLDL-c levels in the population stratified by therapy and prior major CVD events. For each subgroup of patients, we show numbers and percentages in the various LDL-c target rangeBack to article page